The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2
Open accessAbstract
In mutant superoxide dismutase (SOD1)-linked amyotrophic lateral sclerosis (ALS), accumulation of misfolded mutant SOD1 in spinal cord mitochondria is thought to cause mitochondrial dysfunction. Whether mutant SOD1 is toxic per se or whether it damages the mitochondria through interactions with other mitochondrial proteins is not known. We previously identified Bcl-2 as an interacting partner of mutant SOD1 specifically in spinal cord, but not in liver, mitochondria of SOD1 mice and patients. We now show that mutant SOD1 toxicity relies on this interaction. Mutant SOD1 induces mitochondrial morphological changes and compromises mitochondrial membrane integrity leading to release of Cytochrome C only in the presence of Bcl-2. In cells, mouse and human spinal cord with SOD1 mutations, the binding to mutant SOD1 triggers a conformational change in Bcl-2 that results in the uncovering of its toxic BH3 domain and conversion of Bcl-2 into a toxic protein. Bcl-2 carrying a mutagenized, non-toxic BH3 domain fails to support mutant SOD1 mitochondrial toxicity. The identification of Bcl-2 as a specific target and active partner in mutant SOD1 mitochondrial toxicity suggests new therapeutic strategies to inhibit the formation of the toxic mutant SOD1/Bcl-2 complex and to prevent mitochondrial damage in ALS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“Three percent of ALS arises from mutations in copper–zinc superoxide dismutase [SOD1 (2)] which acquires new toxic functions not fully defined (1).”
BackgroundSelf-citationMitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598 · cited 1×
“Bcl-2 also directly binds and inhibits the toxic function of pro-death proteins like Bax and BaK (34), and prevents swelling of the mitochondrial matrix and uncontrolled production of reactive oxygen species (20,35).”
BackgroundDirect Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108 · cited 2×
“Upon binding to toxic proteins like Nur77 (24) and p53 (25), Bcl-2 gains a novel toxic function, triggered by a structural modification that exposes the toxic BH3 domain.”
BackgroundMolecular biology of amyotrophic lateral sclerosis: insights from genetics
Pasinelli, P., & Brown, R. H. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1971 · Cited by 1,107 · cited 5×
“This is because: (a) as disease progresses mitochondrial abnormalities precede motor neuron apoptotic death (1); (b) a recent report dissociated motor neuron dysfunction from apoptosis in ALS (28); (c) in neurons, after their conversion into toxic molecules, Bcl-2-like proteins induce mitochondrial alterations and dec…”
BackgroundInfluentialSelf-citationMitochondrial membrane permeabilization in neuronal injury
Galluzzi, L., Blomgren, K., & Kroemer, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2665 · Cited by 418
Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications
Cozzolino, M., Ferri, A., & Teresa Carrì, M. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1760 · Cited by 156
Cited by
The role of mitochondria in amyotrophic lateral sclerosis
Smith, E. F., Shaw, P. J., & De Vos, K. J. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2017.06.052 · Cited by 559
Mitochondrial Diseases of the Brain
Chaturvedi, R. K., & Flint Beal, M. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.018 · Cited by 413
Misfolded Mutant SOD1 Directly Inhibits VDAC1 Conductance in a Mouse Model of Inherited ALS
Israelson, A., Arbel, N., Da Cruz, S., Ilieva, H., Yamanaka, K., Shoshan-Barmatz, V., & Cleveland, D. W. (2010) · Neuron · doi:10.1016/j.neuron.2010.07.019 · Cited by 315
Biochemical basis and metabolic interplay of redox regulation
Zhang, L., Wang, X., Cueto, R., Effi, C., Zhang, Y., Tan, H., Qin, X., Ji, Y., Yang, X., & Wang, H. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101284 · Cited by 308
The Complex Molecular Biology of Amyotrophic Lateral Sclerosis (ALS)
Redler, R. L., & Dokholyan, N. V. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00002-3 · Cited by 172
Li, Q., Vande Velde, C., Israelson, A., Xie, J., Bailey, A. O., Dong, M.-Q., Chun, S.-J., Roy, T., Winer, L., Yates, J. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014862107 · Cited by 169
SOD1, an unexpected novel target for cancer therapy.
Papa, L., Manfredi, G., & Germain, D. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.4 · Cited by 147
“Mutant SOD1 accumulates on the mitochondrial outer membrane [23] where it interacts with some crucial proteins, such as Bcl2 [24] and VDAC [25].”
BackgroundNonnative SOD1 trimer is toxic to motor neurons in a model of amyotrophic lateral sclerosis
Proctor, E. A., Fee, L., Tao, Y., Redler, R. L., Fay, J. M., Zhang, Y., Lv, Z., Mercer, I. P., Deshmukh, M., Lyubchenko, Y. L., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516725113 · Cited by 131
Vinsant, S., Mansfield, C., Jimenez‐Moreno, R., Moore, V. D. G., Yoshikawa, M., Hampton, T. G., Prevette, D., Caress, J., Oppenheim, R. W., & Milligan, C. (2013) · Brain and Behavior · doi:10.1002/brb3.143 · Cited by 105
Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis
Nassif, M., Valenzuela, V., Rojas-Rivera, D., Vidal, R., Matus, S., Castillo, K., Fuentealba, Y., Kroemer, G., Levine, B., & Hetz, C. (2014) · Autophagy · doi:10.4161/auto.28784 · Cited by 100
Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis
Manfredi, G., & Kawamata, H. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.004 · Cited by 76
Kim, H. J., Magranè, J., Starkov, A. A., & Manfredi, G. (2012) · Brain · doi:10.1093/brain/aws208 · Cited by 64
“This protection alleviates the stress on mitochondria that are burdened by bio- energetic defects caused by aberrant interactions of mutant SOD1 with mitochondrial protein, such as Bcl2 (Pedrini et al., 2010) and VDAC (Israelson et al., 2010), and by protein misfold- ing in the intermembrane space (Igoudjil et al., 20…”
BackgroundDuval, N., Sumner, W. A., Andrianakos, A. G., Gray, J. J., Bouchard, R. J., Wilkins, H. M., & Linseman, D. A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00015 · Cited by 16
“Furthermore, mutant SOD1 accumulates at mitochondria where it can bind and aggregate with Bcl-2, inducing a conformational change and possibly unmasking a toxic, pro-apoptotic function of Bcl-2 (Pasinelli et al., 2004; Pedrini et al., 2010).”
BackgroundNavigating the complexities of cell death: Insights into accidental and programmed cell death
Lotfi, M.-S., & Rassouli, F. B. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102586 · Cited by 15
Metadata
- Authors
- Pedrini, S., Sau, D., Guareschi, S., Bogush, M., Brown, R. H., Naniche, N., Kia, A., Trotti, D., & Pasinelli, P.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-05-11
- Volume
- 19
- Issue
- 15
- Pages
- 2974-2986
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2106819616
- Cited by
- 165
- References
- 6
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.